This cohort study examines the steroid-sparing potential and safety profile of interleukin 5 inhibitors for drug reaction with eosinophilia and systemic symptoms.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: